MyFinsight
Home
About
Contact
iova: the income statement
Download
Download image
Net loss
-$91,253K
(-9.23%↓ Y/Y)
Income tax (expense)
benefit
-$2,405K
(-58.22%↓ Y/Y)
Net loss before
income taxes
-$93,658K
(-10.11%↓ Y/Y)
Interest and other
income, net
$1,243K
(-68.96%↓ Y/Y)
Proleukin
$9,973K
Amtagvi
$57,482K
Loss from operations
-$94,901K
(-6.55%↓ Y/Y)
Total net revenue
$67,455K
(12.73%↑ Y/Y)
Total costs and
expenses
$162,356K
(9.98%↑ Y/Y)
Restructuring charges
$5,143K
Depreciation and
amortization
$9,007K
Selling, general, and
administrative
$34,555K
(-12.64%↓ Y/Y)
Research and development
$75,174K
(10.15%↑ Y/Y)
Cost of sales
$38,477K
(-3.38%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)